《平成15年4月28日》由会员分享，可在线阅读，更多相关《平成15年4月28日（11页珍藏版）》请在金锄头文库上搜索。
1、3rd Japan-USA Cancer Treatment Symposium (JUCTS)New Horizons of Targeted Treatment in Radiation OncologyOctober 2 4, 2003 Kyoto Park HotelProgram andCall for RegistrationSecretariat:3rd Japan-US Cancer Treatment Symposium c/o Dept. of Therapeutic Radiology and Oncology Graduate School of Medicine, K
2、yoto University 54 Shogoin-Kawahara-cho, Sakyo-ku Kyoto 606-8507, Japan Tel: +81-75-751-3417, 3419, Fax: +81-75-771-9749 E-mail: jucts_3rdacplan.jpInvitationWe cordially invite you to the 3rd Japan-USA Cancer Treatment Symposium: New Horizons of Targeted Treatment in Radiation Oncology, to be held i
3、n Kyoto, Japan from October 2-4, 2003. This follows the two previous symposia which were held in Hiroshima in 1999 and La Jolla, California in 2001. The role of Radiation Therapy has come to the front because of the increasing incidents of cancer among elderly people and growing desire for higher QO
4、L. The most important task to achieve those goals is to selectively induce damage to cancer cells while minimizing the damage to normal structures. The recent progress in molecular biology in cancer research has led to the development of new concept of anti-cancer agents and molecular- targeted drug
5、s. In addition to cytotoxic or cytostatic effects on cancer cells, they are being investigated as molecular-based radiosensitizers. On the other hand, the progress in Information Technology and Medical Physics has led to the development of Stereotactic Radiosurgery and Intensity Modulated Radiation
6、Therapy (IMRT), as a physical-engineering approach to spatially focus radiation on tumors. In this symposium, American and Japanese leading researchers will convene in order to present and discuss the newest achievements with respect to biological and physical targeting treatment of cancers, and to
7、exchange ideas on how to build up a new therapeutic strategy through integration of biological and physical targeting approaches. Kyoto, the symposium venue had been the capital of Japan for more than 1000 years from 794 A.D. to 1868, and is one of the most historic and beautiful cities in the world
8、. We hope all participants will enjoy the symposium as well as the scenic beauty of Kyoto. We look forward with pleasure to welcoming your participation in the Symposium. The 3rd Japan-USA Cancer Treatment Symposium Organizing committee chairman Masahiro HiraokaGeneral InformationPeriod:October 2 -
9、4, 2003 Venue:Kyoto Park Hotel644-2 Sanju-sangendo-mawarimachi, Higashiyama-kuKyoto 605-0941, JapanTel: +81-75-525-3111 Fax: +81-75-533-1101URL: http:/www.kyopark.co.jp/index_e.htmOrganized by:Kyoto Univ., Dept. of Therapeutic Radiology Targeting Treatment to EGFR-antibody in Head and Neck CancerLuc
10、a Milas11:20- Continuous Superselective Intraarterial Chemotherapy Combined with Radiotherapy for Head and Neck CancerNobukazu Fuwa(continued)13:00- IMRT for Nasopharyngeal TumorsNancy Lee13:40- The Use of Intensity Modulated Radiation Therapy in the Treatment of Brain TumorsShiao Y. Woo14:20- Real-
11、time Tumor-tracking Intensity- synchronized Radiotherapy Hiroki Shirato15:20- IMRT for Prostate Cancer: Image Guidance and HypofractionationAlan Pollack16:00- Clinical Results of Radiation Therapy for Localized Prostate Cancer, and Experimental Data of Molecular Targeting for Enhancement of Radio- s
12、ensitivity in Prostate Cancer Cell LinesTetsuo Akimoto16:40- Imaging of Hypoxic CellsYoshihiro TakaiOctober 3 (Fri.)(continued)9:00- Management of Cancer of the Prostate and Dose Escalation without Increasing ToxicityMack Roach III9:40- Genomic Analysis for Cervical Cancer after RadiotherapyYoko Har
13、ima10:20- Cytoprotection for Management of Lung CancerRitsuko Komaki11:00- Genetic Predictor of EGF Receptor-targeted Therapy for Non-small Cell Lung CancerSaburo Sone11:40- Current Status of 3-D Stereotactic Radiotherapy for Early Lung CancerYasushi Nagata(continued )13:20- The Role of Targeting Th
14、erapy in Breast CancerMasahiro Hiraoka14:00- Molecular Targeting for Breast CancerCatherine C. Park14:40- Chemoradiation for Esophageal Cancer: Current Status in Japan and Future DirectionsSatoshi Ishikura15:40- Targeting RT with Concurrent CT for Cancer of the EsophagusJames D. Cox16:20- Current St
15、atus of High Dose Rate Brachytherapy for Esophageal CancerYutaka HirokawaOctober 4 (Sat.)Panel Discussion 9:00- Integrating the Advances in Radiotherapy and Biological ImagingC. Clifton Ling9:40- Potential Molecular Targets in Radiation TherapyNorio Mitsuhashi10:20- Integration of Hypoxia Imaging in
16、 Cancer TreatmentK.S. Clifford Chao11:00-12:00 General Discussion joined by other discussantschaired by Komaki 75 min. Fare: 3,490 for reserved seats, 2,980 for non- reserved seats. 2.An airport limousine bus service. Buses depart every hour. Traveling time; 105 min. Fare; 2,300.Participants arriving at New Tokyo (Narita) International Airport, please contact the secretariat. Passport and Visa All foreign visitors ent
